UBE Corporation · TSE:4208
UBE — Q1 FY2018 Earnings Presentation
22 slides from UBE's earnings presentation, Jul 31, 2018
Slide 1: Financial Results for the 1st Quarter FY2018
Financial Results for the 1st Quarter FY2018 July 31, 2018
Slide 2: Scope of Consolidation
1st Quarter of the FY2018 Scope of Consolidation End of FY2017 End of FY2018 1Q Difference Item Notes (A) (B) （B) - （A) Number of consolidated 70 70 0 subsidiaries Number of equity method 24 24 0 affiliates Total 94 94 0 2
Slide 3: Environmental Factors
1st Quarter of the FY2018 Environmental Factors FY2017 1Q FY2018 1Q Difference Item (A) (B) (B) - (A) Exchange Rate Yen/$ 111.1 109.1 -2.0 489 616 127 Naphtha CIF $/ｔ Domestic Yen/KL 39,700 48,400 8,700 Material Price Benzene(ACP) $/ｔ 787 850 63 Australian $/ｔ 97.0 125.0 28.0 Coal (CIF) Yen/t 10,776
Slide 4: Major P/L Items
1st Quarter of the FY2018 Major P/L Items (Billions of yen) FY2017 1Q FY2018 1Q Difference Percentage Item (A) (B) (B) - (A) change Net sales 159.6 169.0 9.4 5.9% Operating profit 9.0 6.1 -2.9 -32.8% Ordinary profit 10.1 10.2 0.0 0.6% Profit attributable to 6.5 6.9 0.3 5.3% owners of parent 4
Slide 5: Net Sales and Operating Profit by Segment
1st Quarter of the FY2018 Net Sales and Operating Profit by Segment (Billions of yen) FY2017 1Q FY2018 1Q Difference Segment (A) (B) (B) - (A) Chemicals 73.3 73.5 0.1 Pharmaceutical 2.4 1.7 -0.7 Net sales Cement & Construction Materials 57.2 59.4 2.2 Machinery 16.2 18.7 2.5 Energy & Environment 15.3
Slide 6: Analysis - Total
1st Quarter of the FY2018 Analysis - Total (Billions of yen) Net Sales Difference of operating profit Chemicals 0.1 200.0 +9.4 159.6 169.0 Pharmaceutical -0.7 Price ※1 -5.0 Cement & Construction Materials 2.2 合成ゴム 69.0 Machinery 2.5 100.0 Energy & Environment 3.0 Volume 1.1 Others 0.0 Adjustment 2.1
Slide 7: Analysis - Chemicals
1st Quarter of the FY2018 Analysis - Chemicals (Billions of yen) Net Sales Difference of operating profit Nylon/Caprolactam chain 2.7 Price ※1 -4.8 +0.1 Synthetic rubber -3.6 合成ゴム 69.0 Battery Materials and Fine Chemicals 0.9 Polyimide and Specialty Products 0.2 Volume 1.2 etc カプロラクタム -6 0 Fixed Cos
Slide 8: Analysis - Pharmaceutical
1st Quarter of the FY2018 Analysis - Pharmaceutical (Billions of yen) Net Sales Difference of operating profit -0.7 Price ※1 -0.0 Volume -0.3 -30.0% Decreased Fixed Cost and Others ※2 -0.6 Operating profit Total -0.8 -0.8 *1: Including both selling and purchase change － *2: Including inventory valua
Slide 9: Analysis – Cement & Construction Materials
1st Quarter of the FY2018 Analysis – Cement & Construction Materials (Billions of yen) Net Sales Difference of operating profit +2.2 Price ※1 -0.0 Cement and Ready-mixed concrete 1.2 69.0 Construction materials and 0.7 Limestone related products Volume 0.3 etc -6 0 4.0% Increased Fixed Cost and Othe
Slide 10: Analysis - Machinery
1st Quarter of the FY2018 Analysis - Machinery (Billions of yen) Net Sales Difference of operating profit +2.5 Price ※1 -0.3 69.0 Volume 0.2 -6 0 15.6% Increased Fixed Cost and Others ※2 -0.0 Operating profit Total -0.1 -0.1 *1: Including both selling and purchase change -43.5% Decreased *2: Includi
Slide 11: Analysis – Energy & Environment
1st Quarter of the FY2018 Analysis – Energy & Environment (Billions of yen) Net Sales Difference of operating profit +3.0 Price ※1 0.2 Coal 2.5 69.0 Power 0.6 Volume -0.2 -6 0 20.2% Increased Fixed Cost and Others ※2 0.7 Operating profit Total 0.6 +0.6 Coal -0.1 Power 0.7 *1: Including both selling
Slide 12: Operating Profit – Profit attributable to owners of parent
1st Quarter of the FY2018 Operating Profit – Profit attributable to owners of parent (Billions of yen) FY2017 1Q FY2018 1Q Difference Item (A) (B) (B) - (A) Operating profit 9.0 6.1 -2.9 Non-operating income/expenses 1.0 4.1 3.0 Net Interests expenses 0.3 1.2 0.8 Share of profit of entities accounte
Slide 13: Consolidated Balance Sheet
1st Quarter of the FY2018 Consolidated Balance Sheet (Billions of yen) End of FY2017 End of FY2018 １Q Difference Item (A) (B) (B) - (A) Current assets 316.8 303.2 -13.6 Fixed assets 425.4 422.1 -3.2 Total assets 742.4 725.5 -16.8 Interest-bearing debts 195.5 185.2 -10.2 Other liabilities 210.0 207.0
Slide 14: Consolidated Statements of Cash Flows
1st Quarter of the FY2018 Consolidated Statements of Cash Flows (Billions of yen) Item FY2017 1Q FY2018 1Q Profit before income taxes 10.1 A.Cash flows from operating activities 19.0 13.0 Depreciation and amortization 8.9 Income taxes paid -6.4, etc. B.Cash flows from investing activities -7.7 -8.8
Slide 15: Reference
Reference 15
Slide 16: Analysis of Operating Profit - All Segments
Reference: 1st Quarter of FY2018 Analysis of Operating Profit - All Segments （Billions of yen） Operating profit Segment Fixed cost FY2017 1Q FY2018 1Q Difference Price Volume and others (A) (B) (B) - (A) *1 *2 Chemicals 6.1 3.6 -2.5 -4.8 1.2 1.2 Pharmaceutical 0.7 -0.0 -0.8 -0.0 -0.3 -0.6 Cement & c
Slide 17: Progress of Major P/L Items
Reference: 1st Quarter of FY2018 Progress of Major P/L Items (Billions of yen) FY2017 (A) FY2018 (B) Difference (B) - (A) Item 1Q 1Q 1Q （Progress） （Progress） 159.6 169.0 Net sales 695.5 740.0 44.5 9.4 (22.9%) (22.8%) 9.0 6.1 Operating profit 50.2 44.0 -6.2 -2.9 (18.1%) (13.9%) 10.1 10.2 Ordinary pro
Slide 18: Net Sales by Segment
Reference: 1st Quarter of the FY2018 Net Sales (Billions of yen) FY2018 Full-year Segment (Forecast) Progress 1Q 2Q 3Q 4Q Total Chemicals 73.5 - - - 73.5 320.0 23.0% Pharmaceutical 1.7 - - - 1.7 10.0 17.0% Cement & Construction 59.4 - - - 59.4 250.0 23.8% Materials Machinery 18.7 - - - 18.7 100.0 18
Slide 19: Operating Profit by Segment
Reference: 1st Quarter of the FY2018 Operating Profit (Billions of yen) FY2018 Full-year Segment (Forecast) Progress 1Q 2Q 3Q 4Q Total Chemicals 3.6 - - - 3.6 22.5 16.0% Pharmaceutical -0.0 - - - -0.0 0.5 - Cement & Construction 2.0 - - - 2.0 12.5 16.0% Materials Machinery 0.1 - - - 0.1 6.0 1.7% Ene
Slide 20: Consolidated Key Indicators
Reference: 1st Quarter of the FY2018 Consolidated Key Indicators (Billions of yen) FY2018 full-year FY2017 Item FY2017 1Q FY2018 1Q (Forecast) full-year Capital investment 5.9 7.2 40.0 40.3 Depreciation and amortization 8.5 8.9 37.0 35.3 R&D expenses 3.3 3.2 14.0 13.2 Adjusted operating profit 10.7
Slide 21: Consolidated Major Subsidiaries
Reference: 1st Quarter of the FY2018 Consolidated Major Subsidiaries (Billions of yen) Net Difference of Sales operating Subsidiaries and affiliates Business profit from FY2018 1Q FY2017 1Q Manufacture and sales of caprolactam, ammonium sulfate, nylon, and UBE Corporation Europe, S.A. Unipersonal fi
Slide 22: Forward-looking statements notice
This presentation material contains forward-looking statements concerning UBEʼs future plans, strategies, and performance. These forward-looking statements are not historical facts; rather, they represent assumptions and beliefs based on economic, financial, and competitive date currently available.